Overview

Datavant specializes in health data technology, focusing on the secure exchange of patient information while maintaining privacy. The company's main product is software that de-identifies patient health data, removing personal identifiers and linking records from various sources. This allows healthcare providers, researchers, and other stakeholders to share and access health data securely, which is crucial for research, treatment, and public health initiatives. For instance, during the COVID-19 pandemic, Datavant's technology helped connect different datasets to analyze the virus's effects on populations. Unlike many competitors, Datavant operates on a software-as-a-service (SaaS) model, charging subscription fees that vary based on client size and data complexity. The goal of Datavant is to enhance data interoperability in the healthcare sector while ensuring patient privacy.

Simplify's Take

What believers are saying

• Growing demand for de-identified data solutions boosts Datavant's market potential.
• Partnerships with pharmaceutical companies enhance Datavant's position in clinical research.
• Expansion of telehealth services increases need for Datavant's secure data exchange solutions.

What critics are saying

• Increased competition from Avandra threatens Datavant's market position.
• A recent phishing attack exposed vulnerabilities in Datavant's cybersecurity measures.
• Regulatory hurdles in Europe may impact Datavant's expansion with Promptly Health.

What makes Datavant unique

• Datavant specializes in de-identifying and linking patient health data securely.
• The company has a vast network of over 70,000 hospitals and clinics.
• Datavant's SaaS model provides customizable solutions for diverse healthcare clients.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$78.3M

Above

Industry Average

Funded Over

2 Rounds

Notable Investors:

Founders FundSoftBank

Notable Investors:

Founders FundSoftBank

$40,000,000

Series B

Oct 2020

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.

Series B Funding Comparison

Above Average

Industry standards

Ind Avg. $35M

$4M

$30M

$40M

$45M

$65M

$100M

View all funding stages